[Successful treatment of a Lambert-Eaton myasthenic syndrome patient with 3,4-diaminopyridine].
Matsushima
Masaaki
M
Department of Neurology, Hokkaido University Graduate School of Medicine, Sapporo.
Yaguchi
Hiroaki
H
Kishimoto
Riichiro
R
Tsuji
Sachiko
S
Yabe
Ichiro
I
Sasaki
Hidenao
H
Nakadate
Megumi
M
Shiraishi
Hirokazu
H
Motomura
Masakatsu
M
D015761:4-Aminopyridine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D000077770:Amifampridine; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D016190:Carboplatin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D006801:Humans; D015624:Lambert-Eaton Myasthenic Syndrome / Q000150:complications* / Q000188:drug therapy*; D008175:Lung Neoplasms / Q000150:complications* / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D011729:Pyridostigmine Bromide / Q000008:administration & dosage; D016896:Treatment Outcome